Characterization and evaluation of patients anticoagulated with warfarin in relation to the complexity of pharmacotherapy
DOI:
https://doi.org/10.15343/0104-7809.202347e15282023PKeywords:
Warfarin, Health Literacy, Anticoagulants, Cooperation and Adherence to Treatment, PolypharmacyAbstract
Diagnosis and treatment of sustained arrhythmias are part of the clinical routine, with one of the most frequent arrhythmias being Atrial Fibrillation (AF). To prevent thromboembolic events in patients with AF, oral anticoagulation is recommended, particularly warfarin. Despite its importance, this medication has a narrow therapeutic range, which means that small changes in treatment generate a risk of thrombotic or hemorrhagic events. Among these changes, adherence to other medications in use, changes in the use of these medications by prescribers and self-medication stand out. There are several interactions between warfarin and other medications for continuous use, with the belief that the complexity of the prescription may interfere with the clinical outcomes of anticoagulant therapy. The objective of the study was to characterize patients followed in an anticoagulation outpatient clinic in relation to the Pharmacotherapy Complexity Index. To identify the complexity of pharmacotherapy, prescriptions for other medications in use, prescribed by primary health care doctors, were considered. The Medication Regimen Complexity Index (MRCI) instrument was used. Complexity, understood as the form of administration, dosage and pharmaceutical form, factors that interfere with adherence to anticoagulant therapy, was subdivided into three complexity levels: low, moderate and high, as indicated in the literature. The complexity analysis was carried out by two researchers independently, considering the criteria as per MRCI guidance. This is a descriptive study carried out in two anticoagulation clinics, located in Minas Gerais. During the research, patients were monitored in two anticoagulation clinics in Brazil, using warfarin, and were invited to participate in a clinical trial between December 2018 and February 2019, and a selection was subsequently made for the present study. A total of 93 patients were included in the study, the average age was 63 years and the majority were female (68.8%). Atrial fibrillation was the most predominant OAC indication (92.5%). The average number of medications used was 7.0. The majority of patients with pharmacotherapy classified as high (38, 6.5%) and medium complexity (24, 80.7%) presented inadequate TTR. The present study identified that there is a predominance of patients with high complexity of pharmacotherapy, which may indicate the need for additional care in relation to anticoagulant treatment. Therefore, in cases of patients with inadequate control of oral anticoagulation, it is recommended that aspects of the complexity of pharmacotherapy be incorporated into the educational approach.
Downloads
References
Cintra FD, Figueiredo MJ. Fibrilação Atrial (Parte 1): fisiopatologia, fatores de risco e bases terapêuticas. Arquivos Bras de Cardiol. 2021, 116(1):129-139. DOI: 10.36660/abc.20200485.
Chylova M, Motovska Z, Fialova A, et al. The effect of warfarin administration on platelet aggregation. Bratisl Lek Listy. 2021;122(5):320- 324. DOI: 10.4149/BLL_2021_054. PMID: 33848181.
Barbosa RA, Mendes PM, Ferro SN, et al. Atenção farmacêutica a pacientes em uso de varfarina. Saúde & Ciên Em Ação. 2018; 4(1):47-70.
Melchiors AC, Correr CJ, Fernández-Llimos F. Tradução e validação para o português do Medication Regimen Complexity Index. Arq Bras Cardiol 2007;89(4):210-18. DOI: 10.1590/S0066-782X2007001600001
Perez MV, Wang PJ, Larson JC, et al. Effects of postmenopausal hormone therapy on incident atrial fibrillation: the Women‟s Health Initiative randomized controlled trials. Circ Arrhythm Electrophysiol. 2012;5(6):1108-16. DOI: 10.1161/CIRCEP.112.972224.
Wimmer BC, Cross AJ, Jokanovic N, et al. Clinical outcomes associated with medication regimen complexity in older people: a systematic review. J Am Geriatr Soc. 2017;65(4):747. DOI: 10.1111/jgs.14682.
January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):1-76. DOI: 10.1016/j.jacc.2014.03.022.
Ferreira JM, Galato D, Melo AC. Medication regimen complexity in adults and the elderly in a primary healthcare setting: determination of high and low complexities. Pharm Pract (Granada). 2015;13(4):1-9. DOI: 10.18549/PharmPract.2015.04.659.
Tavares NU, Bertoldi AD, Mengue SS, et al. Fatores associados à baixa adesão ao tratamento farmacológico de doenças crônicas no Brasil. Rev. Saúde Pública. 2016; 50(2):10.
Nuno L. Varfarina: uma revisão baseada na evidência das interações alimentares e medicamentosas. Rev Port Clin Geral. 2008; 24(4):475-82.
Campos NL, Andrade RR, Silva MA. Anticoagulação oral em portadores de próteses valvares cardíacas mecânicas. Experiência de dez anos. Rev Bras Cir Cardiovasc. 2010; 25(4):457-465.
Mouteira HMS. Análise descritiva do índice de complexidade da farmacoterapia e identificação de medicamentos potencialmente perigosos numa população geriátrica institucionalizada [dissertação de mestrado]. Coimbra: Faculdade de Farmácia da Universidade de Coimbra; 2017
Pinto IV, Reis AM, Brasil CC, et al. Avaliação da compreensão da farmacoterapia entre idosos atendidos na Atenção Primária à Saúde de Belo Horizonte, MG, Brasil. Ciência saúde coletiva. 2016; 21(11): 3469-3481.
Rose AJ, Delate T, Ozonoff A, et al. Comparison of the abilities of summary measures of international normalized ratio control to predict clinically relevant bleeding. Circ Cardiovasc Qual Outcomes. 2015;8(5):524-31. DOI: 10.1161/CIRCOUTCOMES.115.001768.
Martins MA, Carlos PP, Ribeiro DD, et al. Warfarin drug interactions: a comparative evaluation of the lists provided by five information sources. Eur J Clin Pharmacol 2011;67(12):1301-8. DOI: 10.1007/s00228-011-1086-4.
Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert. Opin Drug Saf. 2014;13(1):57–65. DOI: 10.1517/14740338.2013.827660.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 O Mundo da Saúde
This work is licensed under a Creative Commons Attribution 4.0 International License.